Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
67 studies found for:    Open Studies | gastrointestinal diseases | NIDDK
Show Display Options
Rank Status Study
21 Recruiting Biliary Atresia Research Consortium
Conditions: Biliary Atresia;   Cholestasis
Intervention:
22 Recruiting Neuromodulation Therapy for Fecal Incontinence
Condition: Fecal Incontinence
Intervention: Procedure: Repetitive magnetic stimulation
23 Recruiting Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Condition: Irritable Bowel Syndrome (IBS)
Interventions: Other: Fructan;   Other: Maltodextrin
24 Recruiting DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
Condition: Diverticulitis
Intervention:
25 Recruiting Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
Conditions: Liver Diseases;   Portal Hypertension
Intervention: Drug: SHAPE measurement (Sonazoid ultrasoud contrast agent)
26 Recruiting Fat Malabsorption in Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Drug: Creon36™
27 Recruiting Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial
Condition: Gastroesophageal Reflux Disease
Intervention: Other: Study
28 Recruiting Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
Conditions: Irritable Bowel Syndrome;   Ulcerative Colitis;   Inflammatory Bowel Disease
Intervention:
29 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
Intervention:
30 Not yet recruiting FibroScan™ in Pediatric Cholestatic Liver Disease Study Protocol
Conditions: Biliary Atresia;   Alagille Syndrome;   Alpha1 Anti-Trypsin Deficiency;   Portal Hypertension;   Liver Fibrosis;   Cholestasis
Intervention: Other: Liver Stiffness Measurement (LSM)
31 Not yet recruiting MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
Conditions: Cystic Fibrosis Liver Disease;   Pancreatic Insufficiency
Intervention: Procedure: MRI
32 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
33 Recruiting Mitochondrial Function in Patients With Severe Liver Disease
Conditions: Hepatic Insufficiency;   Hypoalbuminemia
Intervention: Other: Orally administered labeled glycerol
34 Recruiting Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure
Conditions: Acute Liver Failure;   Acute Liver Injury
Intervention: Drug: Ornithine phenylacetate
35 Recruiting Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Oral Viscous Budesonide;   Drug: Fluticasone MDI;   Drug: Placebo slurry;   Drug: Placebo inhaler
36 Recruiting Mucosal Impedance in Pediatric Population
Conditions: Gastroesophageal Reflux Disease (GERD);   Eosinophilic Esophagitis (EoE);   Functional Dyspepsia
Intervention: Procedure: Standard of Care esophagogastroduodenoscopy (EGD) with mucosal impedance testing
37 Recruiting Predicting Risk of Cancer in Barrett's Esophagus
Conditions: Barrett Esophagus;   Esophageal Neoplasm;   Gastroesophageal Reflux
Intervention:
38 Recruiting Mechanisms and Management of Infant Dysphagia
Conditions: Dysphagia;   Airway Aspiration;   Airway Penetration
Interventions: Other: Slower Flow Rate;   Other: Thickened Formula
39 Recruiting Drug-Induced Liver Injury (DILN)Network Retrospective
Condition: Drug Induced Liver Injury
Intervention:
40 Recruiting CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Glucagon;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.